Literature DB >> 16627292

Adventures in vascular biology: a tale of two mediators.

S Moncada1.   

Abstract

I would like to thank the Royal Society for inviting me to deliver the Croonian Lecture. In so doing, the Society is adding my name to a list of very distinguished scientists who, since 1738, have preceded me in this task. This is, indeed, a great honour. For most of my research career my main interest has been the understanding of the normal functioning of the blood vessel wall and the way this is affected in pathology. During this time, our knowledge of these subjects has grown to such an extent that many people now believe that the conquering of vascular disease is a real possibility in the foreseeable future. My lecture concerns the discovery of two substances, prostacyclin and nitric oxide. I would like to describe the moments of insight and some of the critical experiments that contributed significantly to the uncovering of their roles in vascular biology. The process was often adventurous, hence the title of this lecture. It is the excitement of the adventure that I would like to convey in the text that follows.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627292      PMCID: PMC1609404          DOI: 10.1098/rstb.2005.1775

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  235 in total

1.  Parsing an enigma: the pharmacodynamics of aspirin resistance.

Authors:  Garret A FitzGerald
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

2.  Vioxx risk could signify trouble in class.

Authors:  Simon Frantz
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

3.  Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents.

Authors:  B B Vargaftig; N Dao
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

4.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases.

Authors:  M W Cleeter; J M Cooper; V M Darley-Usmar; S Moncada; A H Schapira
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

5.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids.

Authors:  F P Nijkamp; R J Flower; S Moncada; J R Vane
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

7.  Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.

Authors:  G A FitzGerald; B Smith; A K Pedersen; A R Brash
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

8.  Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

9.  Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.

Authors:  Orina A Belton; Angela Duffy; Sinead Toomey; Desmond J Fitzgerald
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

Review 10.  Endothelial dysfunction in coronary artery disease.

Authors:  T F Lüscher; F C Tanner; M R Tschudi; G Noll
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

View more
  23 in total

Review 1.  Vascular effects of prostacyclin: does activation of PPARδ play a role?

Authors:  Zvonimir S Katusic; Anantha V Santhanam; Tongrong He
Journal:  Trends Pharmacol Sci       Date:  2012-06-23       Impact factor: 14.819

2.  Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.

Authors:  Xinli Hu; Dorothee Atzler; Xin Xu; Ping Zhang; Haipeng Guo; Zhongbing Lu; John Fassett; Edzard Schwedhelm; Rainer H Böger; Robert J Bache; Yingjie Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

Review 3.  Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.

Authors:  Michalis Hamilos; Stylianos Petousis; Fragiskos Parthenakis
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

4.  Effect of oral carbohydrate with amino acid solution on serum oxidative/anti-oxidative status in healthy volunteers.

Authors:  Yasuo M Tsutsumi; Takuro Oyama; Nami Kakuta; Yousuke T Horikawa; Katsuyoshi Kume; Yoko Sakai; Rie Tsutsumi; Katsuya Tanaka
Journal:  J Anesth       Date:  2017-04-18       Impact factor: 2.078

5.  Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.

Authors:  Takahiro Osawa; Noritaka Ohga; Yasuhiro Hida; Kazuko Kitayama; Kosuke Akiyama; Yuichiro Onodera; Manabu Fujie; Nobuo Shinohara; Masanobu Shindoh; Katsuya Nonomura; Kyoko Hida
Journal:  Cancer Sci       Date:  2012-04-17       Impact factor: 6.716

6.  Adenosine and blood platelets.

Authors:  Hillary A Johnston-Cox; Katya Ravid
Journal:  Purinergic Signal       Date:  2011-02-08       Impact factor: 3.765

7.  VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost.

Authors:  Anna A Birukova; Yufeng Tian; Oleksii Dubrovskyi; Noureddine Zebda; Nicolene Sarich; Xinyong Tian; Yingxiao Wang; Konstantin G Birukov
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

8.  Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.

Authors:  Anna A Birukova; Tatiana Zagranichnaya; Panfeng Fu; Elena Alekseeva; Weiguo Chen; Jeffrey R Jacobson; Konstantin G Birukov
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

Review 9.  Blood flow modulation of vascular dynamics.

Authors:  Juhyun Lee; René R Sevag Packard; Tzung K Hsiai
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

10.  The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.

Authors:  A C Mendes-Ribeiro; G E Mann; L R de Meirelles; M B Moss; C Matsuura; T M C Brunini
Journal:  Open Biochem J       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.